Literature DB >> 19506976

Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy.

Jun Huang1, Bin-Kui Li, Gui-Hua Chen, Jin-Qing Li, Ya-Qi Zhang, Guo-Hui Li, Yun-Fei Yuan.   

Abstract

OBJECTIVE: The present study aimed to evaluate the long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma (HCC) undergoing hepatectomy.
MATERIAL AND METHODS: From January 1983 to December 2006, 2,283 patients with HCC received hepatectomy in Sun Yat-sen University Cancer Center. The clinicopathological data and treatment outcomes of 67 elderly HCC patients (elderly group, > or =70 years of age) and 268 patients (control group, <70 years of age) who were selected randomly from the 2216 younger patients were compared retrospectively.
RESULTS: The elderly HCC patients had lower hepatitis B surface antigen-positive rate (P < 0.001), lower rate of marked alpha-fetoprotein elevation (P = 0.004), higher infection rate of hepatitis C virus (P = 0.010), more preoperative comorbidities (P < 0.001), higher rate of tumor encapsulation (P = 0.040), and better overall survival rate (P = 0.017); whereas there were no significant differences between these two groups in other factors, including gender ratio, liver function, accompanying cirrhosis, pathological tumor-node-metastasis (pTNM) staging, satellite nodules, vascular invasion, tumor rupture, resection margin, intraoperative blood loss, incidence of postoperative complications, hospital mortality, and disease-free survival rate. Multivariate analysis showed that pTNM staging was an independent prognostic factor of long-term survival in elderly patients with HCC.
CONCLUSION: HCC in the elderly was less HBV-associated, less advanced, and less aggressive. Hepatectomy for selected elderly patients with HCC possibly have a better curative effect compared with younger patients. For the elderly patients without preoperative comorbidities or with controlled comorbidities, hepatectomy is a safe and effective treatment. pTNM staging is the only independent predictor of postoperative overall survival in elderly HCC patients.

Entities:  

Mesh:

Year:  2009        PMID: 19506976     DOI: 10.1007/s11605-009-0933-4

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  34 in total

1.  Cancer Incidence in Five Continents. Comparability and quality of data.

Authors:  D M Parkin; C S Muir
Journal:  IARC Sci Publ       Date:  1992

2.  Clinical management of recurrent hepatocellular carcinoma.

Authors:  P H Lee; W J Lin; Y M Tsang; R H Hu; J C Sheu; M Y Lai; H C Hsu; W May; C S Lee
Journal:  Ann Surg       Date:  1995-11       Impact factor: 12.969

3.  alpha-Fetoprotein induces suppressor T cells in vitro.

Authors:  R A Murgita; E A Goidl; S Kontianen; H Wigzell
Journal:  Nature       Date:  1977-05-19       Impact factor: 49.962

4.  Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma.

Authors:  T J Tsai; G Y Chau; W Y Lui; S H Tsay; K L King; C C Loong; C Y Hsia; C W Wu
Journal:  Surgery       Date:  2000-06       Impact factor: 3.982

5.  Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management.

Authors:  R T Poon; S T Fan; C M Lo; C L Liu; H Ngan; I O Ng; J Wong
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

6.  Repeat hepatectomy is the most useful treatment for recurrent hepatocellular carcinoma.

Authors:  K Sugimachi; S Maehara; S Tanaka; M Shimada; K Sugimachi
Journal:  J Hepatobiliary Pancreat Surg       Date:  2001

7.  Alpha-fetoprotein enhances the proliferation of human hepatoma cells in vitro.

Authors:  X W Wang; H Xie
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

8.  Changed clinical aspects of primary liver cancer in China during the past 30 years.

Authors:  Bing-Hui Yang; Jing-Lin Xia; Li-Wen Huang; Zhao-You Tang; Ming-Shan Chen; Jin-Qing Li; An-Min Liang; Qin-Guo Mo; Hui-Shan Lu; Chao-Liu Dai; Lu-Nan Yan; Zhi-Jian Yu; Rong-Sheng Rao; Le-Qun Li; Zhi-Xiong Su; Zhuang-Wei Fang
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2004-05

9.  Liver resection in the aged (seventy years or older) with hepatocellular carcinoma.

Authors:  N Nagasue; Y C Chang; Y Takemoto; H Taniura; H Kohno; T Nakamura
Journal:  Surgery       Date:  1993-02       Impact factor: 3.982

10.  High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.

Authors:  Shian-Yang Peng; Wei J Chen; Po-Lin Lai; Yun-Ming Jeng; Jin-Chuan Sheu; Hey-Chi Hsu
Journal:  Int J Cancer       Date:  2004-10-20       Impact factor: 7.396

View more
  39 in total

1.  Hepatectomy in elderly patients: does age matter?

Authors:  Yanming Zhou; Xiaofeng Zhang; Zuobing Zhang; Xiaobin Liu; Lupeng Wu; Yumin Li; Bin Li
Journal:  World J Surg       Date:  2013-12       Impact factor: 3.352

2.  Surgical outcomes and clinical characteristics of elderly patients undergoing curative hepatectomy for hepatocellular carcinoma.

Authors:  Fumitoshi Hirokawa; Michihiro Hayashi; Yoshiharu Miyamoto; Mitsuhiro Asakuma; Tetsunosuke Shimizu; Koji Komeda; Yoshihiro Inoue; Atsushi Takeshita; Yuro Shibayama; Kazuhisa Uchiyama
Journal:  J Gastrointest Surg       Date:  2013-09-04       Impact factor: 3.452

3.  Effect of Age on Liver Function in Patients Undergoing Partial Hepatectomy.

Authors:  T M Lodewick; P H Alizai; R M van Dam; A A J Roeth; M Schmeding; C Heidenhain; A Andert; N Gassler; C H C Dejong; U P Neumann
Journal:  Dig Surg       Date:  2017-02-15       Impact factor: 2.588

4.  Patient and tumour biology predict survival beyond the Milan criteria in liver transplantation for hepatocellular carcinoma.

Authors:  Andreas Andreou; Safak Gül; Andreas Pascher; Wenzel Schöning; Hussein Al-Abadi; Marcus Bahra; Fritz Klein; Timm Denecke; Benjamin Strücker; Gero Puhl; Johann Pratschke; Daniel Seehofer
Journal:  HPB (Oxford)       Date:  2014-09-28       Impact factor: 3.647

Review 5.  Management of hepatocellular carcinoma in the elderly.

Authors:  Mauro Borzio; Elena Dionigi; Giancarlo Parisi; Ivana Raguzzi; Rodolfo Sacco
Journal:  World J Hepatol       Date:  2015-06-18

6.  A comparative analysis of hepatocellular carcinoma after hepatic resection in young versus elderly patients.

Authors:  Cho Rok Lee; Jin Hong Lim; Sung Hoon Kim; Sang Hoon Ahn; Young Nyun Park; Gi Hong Choi; Jin Sub Choi; Kyung Sik Kim
Journal:  J Gastrointest Surg       Date:  2012-07-19       Impact factor: 3.452

Review 7.  Impact of aging on morbidity and mortality after liver resection: a systematic review and meta-analysis.

Authors:  Toru Mizuguchi; Masaki Kawamoto; Makoto Meguro; Kenji Okita; Shigenori Ota; Masayuki Ishii; Tomomi Ueki; Toshihiko Nishidate; Yasutoshi Kimura; Tomohisa Furuhata; Koichi Hirata
Journal:  Surg Today       Date:  2014-02-14       Impact factor: 2.549

8.  Referral patterns and treatment choices for patients with hepatocellular carcinoma: a United States population-based study.

Authors:  Omar Hyder; Rebecca M Dodson; Hari Nathan; Joseph M Herman; David Cosgrove; Ihab Kamel; Jean-Francois H Geschwind; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2013-09-13       Impact factor: 6.113

9.  Totally laparoscopic liver resections for primary and metastatic cancer in the elderly: safety, feasibility and short-term outcomes.

Authors:  Marcello Giuseppe Spampinato; Marianna Arvanitakis; Francesco Puleo; Lucio Mandala; Giuseppe Quarta; Donatella Traisci; Antonella Plaia; Nicola Di Bartolomeo; Giànandrea Baldazzi; Umberto Cillo
Journal:  Surg Endosc       Date:  2012-12-18       Impact factor: 4.584

Review 10.  Hepatocellular carcinoma in the elderly: Meta-analysis and systematic literature review.

Authors:  Annie K Hung; Jennifer Guy
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.